Should all patients with type 2 diabetes receive initial combination therapy: an assessment of the ADVANCE trial.
Duka
Irena
I
Bakris
George L
GL
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007190:Indapamide / Q000494:pharmacology / Q000627:therapeutic use; D020913:Perindopril / Q000494:pharmacology / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016896:Treatment Outcome; D014652:Vascular Diseases / Q000188:drug therapy* / Q000209:etiology
D000959:Antihypertensive Agents; D007190:Indapamide; D020913:Perindopril